JP2023502030A5 - - Google Patents
Info
- Publication number
- JP2023502030A5 JP2023502030A5 JP2022527713A JP2022527713A JP2023502030A5 JP 2023502030 A5 JP2023502030 A5 JP 2023502030A5 JP 2022527713 A JP2022527713 A JP 2022527713A JP 2022527713 A JP2022527713 A JP 2022527713A JP 2023502030 A5 JP2023502030 A5 JP 2023502030A5
- Authority
- JP
- Japan
- Prior art keywords
- peaks
- methyl
- compound
- crystalline
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025132388A JP2025159062A (ja) | 2019-11-14 | 2025-08-07 | 複素環式化合物およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019206311A JP2021080177A (ja) | 2019-11-14 | 2019-11-14 | 複素環化合物及びその用途 |
| JP2019206311 | 2019-11-14 | ||
| PCT/IB2020/000962 WO2021094832A1 (en) | 2019-11-14 | 2020-11-12 | Heterocyclic nmda antagonists |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025132388A Division JP2025159062A (ja) | 2019-11-14 | 2025-08-07 | 複素環式化合物およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023502030A JP2023502030A (ja) | 2023-01-20 |
| JP2023502030A5 true JP2023502030A5 (cg-RX-API-DMAC10.html) | 2023-11-20 |
| JP7726879B2 JP7726879B2 (ja) | 2025-08-20 |
Family
ID=74141594
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019206311A Pending JP2021080177A (ja) | 2019-11-14 | 2019-11-14 | 複素環化合物及びその用途 |
| JP2022527713A Active JP7726879B2 (ja) | 2019-11-14 | 2020-11-12 | 複素環式化合物およびその使用 |
| JP2025132388A Pending JP2025159062A (ja) | 2019-11-14 | 2025-08-07 | 複素環式化合物およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019206311A Pending JP2021080177A (ja) | 2019-11-14 | 2019-11-14 | 複素環化合物及びその用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025132388A Pending JP2025159062A (ja) | 2019-11-14 | 2025-08-07 | 複素環式化合物およびその使用 |
Country Status (21)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12637418B2 (en) | 2019-01-24 | 2026-05-26 | Takeda Pharmaceutical Company Limited | Heterocyclic compounds as antagonist of NMDA |
| TWI873185B (zh) | 2019-09-16 | 2025-02-21 | 日商武田藥品工業股份有限公司 | 唑稠合之嗒-3(2h)-酮衍生物 |
| JP2021050161A (ja) | 2019-09-25 | 2021-04-01 | 武田薬品工業株式会社 | 複素環化合物及びその用途 |
| JP2021080177A (ja) * | 2019-11-14 | 2021-05-27 | 武田薬品工業株式会社 | 複素環化合物及びその用途 |
| WO2026060343A1 (en) | 2024-09-16 | 2026-03-19 | Neurocrine Biosciences, Inc. | Solid forms comprising a nr2b nam antagonist |
Family Cites Families (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2492382A1 (fr) | 1980-10-22 | 1982-04-23 | Synthelabo | Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique |
| US5252563A (en) | 1991-12-19 | 1993-10-12 | G. D. Searle & Company | 5,6,7,8-tetrahydro-imidazo[1,2-a]pyrimidine compounds for treatment of neurotoxic injury |
| CA2191979A1 (en) | 1994-06-20 | 1995-12-28 | Muneo Takatani | Condensed imidazole compounds, their production and use |
| JPH08319288A (ja) | 1994-06-20 | 1996-12-03 | Takeda Chem Ind Ltd | 縮合イミダゾール誘導体、その製造法及び剤 |
| JP3439551B2 (ja) | 1994-11-08 | 2003-08-25 | 富士写真フイルム株式会社 | ハロゲン化銀写真感光材料 |
| CA2214247C (en) | 1995-03-14 | 2004-02-10 | Praecis Pharmaceuticals Incorporated | Modulators of amyloid aggregation |
| US6387938B1 (en) | 1996-07-05 | 2002-05-14 | Mochida Pharmaceutical Co., Ltd. | Benzimidazole derivatives |
| KR20000022398A (ko) | 1996-07-05 | 2000-04-25 | 모치다 에이 | 신규 벤조이미다졸 유도체 |
| EP1586584A1 (en) | 1996-08-27 | 2005-10-19 | Praecis Pharmaceuticals Incorporated | Modulators of beta-amyloid peptide aggregation comprising D-amino acids |
| JP2000159747A (ja) | 1998-09-21 | 2000-06-13 | Takeda Chem Ind Ltd | 新規チオ―ル誘導体、その製造法および用途 |
| US6420415B1 (en) | 1998-09-21 | 2002-07-16 | Takeda Chemical Industries, Ltd. | Thiol compounds, their production and use |
| US6331640B1 (en) | 1998-10-13 | 2001-12-18 | Hoffmann-La Roche Inc. | Diaminopropionic acid derivatives |
| EP1194449B1 (en) | 1999-06-28 | 2010-09-22 | Oklahoma Medical Research Foundation | Inhibitors of memapsin 2 and use thereof |
| US6316474B1 (en) | 1999-10-29 | 2001-11-13 | Merck & Co., Inc. | 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists |
| AU1153601A (en) | 1999-10-29 | 2001-05-08 | Merck Sharp & Dohme Limited | Method to treat pain utilizing benzimidazole NMDA NR2B antagonists |
| US20020151534A1 (en) | 2001-02-02 | 2002-10-17 | Ries Uwe Joerg | Antithrombotic compounds |
| DE10111842A1 (de) | 2001-03-13 | 2002-09-19 | Boehringer Ingelheim Pharma | Antithrombotische Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel |
| EP1390034A4 (en) | 2001-04-03 | 2005-07-13 | Merck & Co Inc | N-SUBSTITUTED NONARYL HETEROCYCLO AMIDYL-NMDA / NR2B ANTAGONISTS |
| JPWO2003035641A1 (ja) | 2001-10-22 | 2005-02-10 | 塩野義製薬株式会社 | 新規カルバモイルピロリドン誘導体 |
| JP2004002405A (ja) | 2002-04-26 | 2004-01-08 | Takeda Chem Ind Ltd | 新規チオール誘導体、その製造法および用途 |
| CA2483515A1 (en) * | 2002-04-26 | 2003-11-06 | Takeda Pharmaceutical Company Limited | Novel thiol derivative, method for producing the same and use thereof |
| MY139563A (en) | 2002-09-04 | 2009-10-30 | Bristol Myers Squibb Co | Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| JP2004161716A (ja) | 2002-11-15 | 2004-06-10 | Takeda Chem Ind Ltd | Jnk阻害剤 |
| CA2521907A1 (en) | 2003-04-10 | 2004-10-21 | Pfizer Inc. | Bicyclic compounds as nr2b receptor antagonists |
| US20050137187A1 (en) | 2003-12-23 | 2005-06-23 | Souers Andrew J. | Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| HUP0401523A3 (en) | 2004-07-29 | 2007-05-02 | Richter Gedeon Vegyeszet | Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them |
| JP5031745B2 (ja) | 2005-08-12 | 2012-09-26 | アストラゼネカ アクチボラグ | 代謝型グルタミン酸受容体増強性イソインドロン |
| US20080234318A1 (en) | 2005-08-31 | 2008-09-25 | Kristjan Gudmundsson | Chemical Compounds |
| AR057218A1 (es) | 2005-12-15 | 2007-11-21 | Astra Ab | Compuestos de oxazolidinona y su uso como pontenciadores del receptor metabotropico de glutamato |
| TWI403320B (zh) | 2005-12-16 | 2013-08-01 | Infinity Discovery Inc | 用於抑制bcl蛋白和結合夥伴間之交互作用的化合物及方法 |
| WO2007098352A2 (en) | 2006-02-16 | 2007-08-30 | Boehringer Ingelheim International Gmbh | Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors |
| WO2009004430A1 (en) * | 2007-06-29 | 2009-01-08 | Pfizer Inc. | N-benzyl oxazolidinones and related heterocycleic compounds as potentiators of glutamate receptors |
| AU2010210426B2 (en) | 2009-02-06 | 2015-06-11 | Imago Pharmaceuticals, Inc. | Inhibitors of Jun N-terminal kinase |
| BR112012021806A2 (pt) | 2010-03-01 | 2015-09-08 | Myrexis Inc | compostos e seus usos terapêusticos. |
| US8404859B2 (en) | 2011-03-16 | 2013-03-26 | Hoffmann-La Roche Inc. | Thiazole and thiophene compounds |
| EP2694509B1 (en) | 2011-04-05 | 2016-05-18 | Pfizer Limited | Pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of tropomyosin-related kinases |
| EP2721029B1 (en) | 2011-06-16 | 2018-07-18 | Merck Sharp & Dohme Corp. | Imidazopyridin-2-one derivatives |
| FR2998892B1 (fr) | 2012-12-04 | 2015-01-02 | Pf Medicament | Derives d'aminocyclobutane, leur procede de preparation et leur utilisation a titre de medicaments |
| AR094929A1 (es) | 2013-02-28 | 2015-09-09 | Bristol Myers Squibb Co | Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2 |
| US9243001B2 (en) | 2013-03-15 | 2016-01-26 | Epizyme, Inc. | Substituted benzene compounds |
| US20160031907A1 (en) | 2013-03-15 | 2016-02-04 | Epizyme, Inc. | Substituted Benzene Compounds |
| CA2939639C (en) | 2014-02-24 | 2023-01-24 | Takeda Gmbh | Uti fusion proteins |
| CN107074788B (zh) | 2014-10-31 | 2019-09-20 | 厦门大学 | 取代杂环衍生物、其制备方法和用途 |
| US10202376B2 (en) | 2014-12-24 | 2019-02-12 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| TWI636041B (zh) | 2015-08-12 | 2018-09-21 | 美國禮來大藥廠 | Cgrp受體拮抗劑 |
| TW201718574A (zh) | 2015-08-12 | 2017-06-01 | 美國禮來大藥廠 | Cgrp受體拮抗劑 |
| WO2017033946A1 (ja) | 2015-08-25 | 2017-03-02 | 武田薬品工業株式会社 | 複素環化合物 |
| PL3439477T3 (pl) | 2016-04-08 | 2020-11-16 | Syngenta Participations Ag | Mikrobiocydowe pochodne oksadiazolowe |
| EP3636281B1 (en) | 2017-05-09 | 2023-11-01 | Zhejiang University | Method for treating depression, and pharmaceutical composition |
| US11230541B2 (en) | 2017-07-28 | 2022-01-25 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| EP3774800B1 (en) | 2018-03-28 | 2024-11-13 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
| JP6806735B2 (ja) | 2018-05-30 | 2021-01-06 | 矢崎総業株式会社 | 車両用回路体および車両用回路体の製造方法 |
| AU2019362061B2 (en) | 2018-10-18 | 2024-09-26 | Essa Pharma Inc | Androgen receptor modulators and methods for their use |
| US12637418B2 (en) | 2019-01-24 | 2026-05-26 | Takeda Pharmaceutical Company Limited | Heterocyclic compounds as antagonist of NMDA |
| WO2020198710A1 (en) | 2019-03-28 | 2020-10-01 | Essa Pharma, Inc. | Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof |
| WO2020196828A1 (ja) | 2019-03-28 | 2020-10-01 | 武田薬品工業株式会社 | 含窒素複素環化合物 |
| JP2021050161A (ja) | 2019-09-25 | 2021-04-01 | 武田薬品工業株式会社 | 複素環化合物及びその用途 |
| JP2021080177A (ja) * | 2019-11-14 | 2021-05-27 | 武田薬品工業株式会社 | 複素環化合物及びその用途 |
-
2019
- 2019-11-14 JP JP2019206311A patent/JP2021080177A/ja active Pending
-
2020
- 2020-11-12 US US17/755,907 patent/US12630509B2/en active Active
- 2020-11-12 PH PH1/2022/551173A patent/PH12022551173A1/en unknown
- 2020-11-12 JP JP2022527713A patent/JP7726879B2/ja active Active
- 2020-11-12 KR KR1020227019888A patent/KR20220102629A/ko active Pending
- 2020-11-12 EP EP20838595.5A patent/EP4058430A1/en active Pending
- 2020-11-12 CR CR20220275A patent/CR20220275A/es unknown
- 2020-11-12 AR ARP200103139A patent/AR120452A1/es unknown
- 2020-11-12 CA CA3158352A patent/CA3158352A1/en active Pending
- 2020-11-12 BR BR112022008367A patent/BR112022008367A2/pt unknown
- 2020-11-12 WO PCT/IB2020/000962 patent/WO2021094832A1/en not_active Ceased
- 2020-11-12 TW TW109139608A patent/TWI908745B/zh active
- 2020-11-12 AU AU2020385250A patent/AU2020385250B2/en active Active
- 2020-11-12 MX MX2022005778A patent/MX2022005778A/es unknown
- 2020-11-12 PE PE2022000751A patent/PE20221767A1/es unknown
- 2020-11-12 CN CN202080079710.1A patent/CN114728900A/zh active Pending
-
2022
- 2022-05-01 IL IL292639A patent/IL292639A/en unknown
- 2022-05-10 JO JOP/2022/0108A patent/JOP20220108A1/ar unknown
- 2022-05-12 CL CL2022001241A patent/CL2022001241A1/es unknown
- 2022-05-12 EC ECSENADI202237602A patent/ECSP22037602A/es unknown
- 2022-05-13 DO DO2022000099A patent/DOP2022000099A/es unknown
- 2022-06-06 CO CONC2022/0008012A patent/CO2022008012A2/es unknown
- 2022-12-22 US US18/087,233 patent/US11834409B2/en active Active
- 2022-12-22 US US18/087,302 patent/US11827601B2/en active Active
-
2025
- 2025-08-07 JP JP2025132388A patent/JP2025159062A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7846132B2 (ja) | Nav1.8阻害薬としてのアリール 3-オキソピペラジンカルボキサミド類及びヘテロアリール 3-オキソピペラジンカルボキサミド類 | |
| JP7555327B2 (ja) | Nlrp3インフラマソーム阻害剤 | |
| CN105073747B (zh) | 杂环化合物及其应用 | |
| JP6832846B2 (ja) | ヘテロ環化合物およびその用途 | |
| TW570917B (en) | Trisubstituted 1,3,5-triazine derivatives | |
| JP2026048891A (ja) | Nav1.8阻害薬としてのシクロアルキル 3-オキソピペラジンカルボキサミド類及びシクロヘテロアルキル 3-オキソピペラジンカルボキサミド類 | |
| JP2015512942A5 (cg-RX-API-DMAC10.html) | ||
| RU2472509C2 (ru) | Способ лечения артрита | |
| JP2014516360A5 (cg-RX-API-DMAC10.html) | ||
| JP2012503018A5 (cg-RX-API-DMAC10.html) | ||
| EA033686B1 (ru) | Гетероциклические соединения, применимые в качестве модуляторов tnf-альфа | |
| JP2011509309A5 (cg-RX-API-DMAC10.html) | ||
| CN105308036A (zh) | 用于激酶调节的化合物和方法及其适应症 | |
| JP2010513519A5 (cg-RX-API-DMAC10.html) | ||
| RU2012131416A (ru) | Ингибиторы фосфатидилинозитол-3-киназы на основе изоиндолинона | |
| HRP20131182T1 (hr) | Novi derivati 6-triazolopiridazinsulfanilbenzotiazola i -benzimidazola, postupak njihovog dobivanja i primjena kao medikamenata i farmaceutskih pripravaka, te nova upotreba kao inhibitora met | |
| JP2013510884A5 (cg-RX-API-DMAC10.html) | ||
| JP2022510925A5 (cg-RX-API-DMAC10.html) | ||
| JP2020533352A5 (cg-RX-API-DMAC10.html) | ||
| JP2010539166A5 (cg-RX-API-DMAC10.html) | ||
| HUE032075T2 (en) | 3-(2-aryl-cycloalkenylmethyl)-oxazolidin-2-one derivatives as cholesterol ester transfer protein (cetp) inhibitors | |
| JP2023512664A5 (cg-RX-API-DMAC10.html) | ||
| JP2011509301A5 (cg-RX-API-DMAC10.html) | ||
| JP2013542267A5 (cg-RX-API-DMAC10.html) | ||
| BR112020005279B1 (pt) | Compostos de 4-[[(7-aminopirazolo[1,5-a]pirimidin-5- il)amino]metil] piperidin-3-ol como inibidores cdk, seus usos, composição farmacêutica e seu método de preparação, métodos in vitro para inibir a função de cdk em uma célula, e para inibir a proliferação celular, inibir a progressão do ciclo celular, promover apoptose ou uma combinação de um ou mais desses, e kit |